Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.9 USD | +2.52% | +4.19% | +0.51% |
May. 16 | Scotiabank Adjusts Price Target on Healthpeak Properties to $23 From $22 | MT |
May. 16 | JPMorgan Adjusts Price Target on Healthpeak Properties to $21 From $19, Keeps Neutral Rating | MT |
Evolution of the average Target Price on Healthpeak Properties, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Healthpeak Properties, Inc.
Scotiabank | |
JPMorgan Chase | |
BMO Capital | |
Wedbush | |
BNP Paribas Exane | |
RBC Capital Markets | |
BofA Securities | |
Deutsche Bank Securities | |
Morgan Stanley | |
Barclays | |
Mizuho Securities | |
Citigroup | |
Jefferies & Co. | |
Evercore ISI | |
Wolfe Research | |
Berenberg Bank | |
Credit Suisse | |
Wells Fargo Securities | |
Argus | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- DOC Stock
- Consensus Healthpeak Properties, Inc.